US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist
  • 15.190
  • +1.100+7.81%
Close Mar 27 16:00 ET
1.08BMarket Cap-3398P/E (TTM)

About Zentalis Pharmaceuticals Company

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in New York, NY.

Company Profile

SymbolZNTL
Company NameZentalis Pharmaceuticals
Listing Date04/03/2020
Issue Price18.00
Founded2014
CEODr. Kimberly Blackwell, M.D.
MarketNASDAQ
Employees168
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1359 Broadway,Suite 801
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10018
Phone1-212-433-3791

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kimberly Blackwell, M.D.
  • Director and Chief Executive Officer
  • 36.61M
  • Dr. Diana F. Hausman, M.D.
  • Chief Medical Officer
  • --
  • Melissa B. Epperly
  • Principal Accounting Officer, Chief Financial Officer and Treasurer
  • 4.03M
  • Dr. Kyle Rasbach, PhD,Pharm.D.
  • Chief Business Officer
  • --
  • Andrea Paul
  • General Counsel and Corporate Secretary
  • 6.21M
  • Cam S. Gallagher
  • Director and President
  • 10.63M
  • David M. Johnson
  • Chairman of the Board
  • 786.05K
  • Dr. Jan Skvarka
  • Independent Director
  • 1.11M
  • Karan S. Takhar
  • Independent Director
  • --
  • Dr. Enoch Kariuki, Pharm.D.
  • Independent Director
  • 666.43K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg